Literature DB >> 14645568

Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype.

Mikael Nilsson1, Kjell-Olof Hedlund, Margareta Thorhagen, Göran Larson, Kari Johansen, Anders Ekspong, Lennart Svensson.   

Abstract

In the present study we report on evolution of calicivirus RNA from a patient with chronic diarrhea (i.e., lasting >2 years) and viral shedding. Partial sequencing of open reading frame 1 (ORF1) from 12 consecutive isolates revealed shedding of a genogroup II virus with relatively few nucleotide changes during a 1-year period. The entire capsid gene (ORF2) was also sequenced from the same isolates and found to contain 1,647 nucleotides encoding a protein of 548 amino acids with similarities to the Arg320 and Mx strains. Comparative sequence analysis of ORF2 revealed 32 amino acid changes during the year. It was notable that the vast majority of the cumulative amino acid changes (8 of 11) appeared within residues 279 to 405 located within the hypervariable domain (P2) of the capsid protein and hence were subject to immune pressure. An interesting and novel observation was that the accumulated amino acid changes in the P2 domain resulted in predicted structural changes, including disappearance of a helix structure, and thus a possible emergence of a new phenotype. FUT2 gene polymorphism characterization revealed that the patient is heterozygous at nucleotide 428 and thus Secretor(+), a finding in accordance with the hypothesis of FUT2 gene polymorphism and calicivirus susceptibility. To our knowledge, this is the first report of RNA evolution of calicivirus in a single individual, and our data suggest an immunity-driven mechanism for viral evolution. We also report on chronic virus excretion, immunoglobulin treatment, and modification of clinical symptoms; our observations from these studies, together with the FUT2 gene characterization, may lead to a better understanding of calicivirus pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645568      PMCID: PMC296070          DOI: 10.1128/jvi.77.24.13117-13124.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Protein secondary structure prediction based on position-specific scoring matrices.

Authors:  D T Jones
Journal:  J Mol Biol       Date:  1999-09-17       Impact factor: 5.469

2.  Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells.

Authors:  L J White; M E Hardy; M K Estes
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Molecular detection and epidemiology of small round-structured viruses in outbreaks of gastroenteritis in the Netherlands.

Authors:  J Vinjé; M P Koopmans
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

4.  The incidence and genetic variability of small round-structured viruses in outbreaks of gastroenteritis in The Netherlands.

Authors:  J Vinjé; S A Altena; M P Koopmans
Journal:  J Infect Dis       Date:  1997-11       Impact factor: 5.226

5.  Molecular basis for erythrocyte Le(a+ b+) and salivary ABH partial-secretor phenotypes: expression of a FUT2 secretor allele with an A-->T mutation at nucleotide 385 correlates with reduced alpha(1,2) fucosyltransferase activity.

Authors:  S Henry; R Mollicone; P Fernandez; B Samuelsson; R Oriol; G Larson
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

6.  Structure of Norwalk virus.

Authors:  B V Prasad; M E Hardy; X Jiang; M K Estes
Journal:  Arch Virol Suppl       Date:  1996

7.  A second nonsecretor allele of the blood group alpha(1,2)fucosyl-transferase gene (FUT2).

Authors:  S Henry; R Mollicone; J B Lowe; B Samuelsson; G Larson
Journal:  Vox Sang       Date:  1996       Impact factor: 2.144

8.  Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial.

Authors:  X L Pang; J Joensuu; T Vesikari
Journal:  Pediatr Infect Dis J       Date:  1999-05       Impact factor: 2.129

9.  A rapid molecular method (polymerase chain reaction with sequence-specific primers) to genotype for ABO blood group and secretor status and its potential for organ transplants.

Authors:  J Procter; J Crawford; M Bunce; K I Welsh
Journal:  Tissue Antigens       Date:  1997-11

10.  Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype.

Authors:  R J Kelly; S Rouquier; D Giorgi; G G Lennon; J B Lowe
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

View more
  83 in total

1.  Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis.

Authors:  Elizabeth A Hurd; Steven E Domino
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

2.  High-resolution x-ray structure and functional analysis of the murine norovirus 1 capsid protein protruding domain.

Authors:  Stefan Taube; John R Rubin; Umesh Katpally; Thomas J Smith; Ann Kendall; Jeanne A Stuckey; Christiane E Wobus
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Evidence of recombination in the norovirus capsid gene.

Authors:  Jacques Rohayem; Julia Münch; Axel Rethwilm
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Evolutionary mechanisms of persistence and diversification of a calicivirus within endemically infected natural host populations.

Authors:  Karen P Coyne; Rosalind M Gaskell; Susan Dawson; Carol J Porter; Alan D Radford
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

Review 5.  Murine norovirus: a model system to study norovirus biology and pathogenesis.

Authors:  Christiane E Wobus; Larissa B Thackray; Herbert W Virgin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  The importance of intergenic recombination in norovirus GII.3 evolution.

Authors:  Jackie E Mahar; Karin Bok; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

7.  Presence of a surface-exposed loop facilitates trypsinization of particles of Sinsiro virus, a genogroup II.3 norovirus.

Authors:  Shantanu Kumar; Wendy Ochoa; Shinichi Kobayashi; Vijay S Reddy
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Kinetics of transmission, infectivity, and genome stability of two novel mouse norovirus isolates in breeding mice.

Authors:  Jennifer A Kelmenson; Darcy P Pomerleau; Stephen Griffey; Weidong Zhang; Michele J Karolak; James R Fahey
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

9.  Type I and type II interferons inhibit the translation of murine norovirus proteins.

Authors:  Harish Changotra; Yali Jia; Tara N Moore; Guangliang Liu; Shannon M Kahan; Stanislav V Sosnovtsev; Stephanie M Karst
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

10.  Pediatric norovirus diarrhea in Nicaragua.

Authors:  Filemon Bucardo; Johan Nordgren; Beatrice Carlsson; Margarita Paniagua; Per-Eric Lindgren; Felix Espinoza; Lennart Svensson
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.